10 GSK AI and data science leaders
GSK AI and machine learning leadership in this group sits at director level and above: nine still hold director, senior director or executive director titles there, and their titles and team names cover R&D, foundation models, sequence learning, vaccines and infectious disease, and global commercial decision science. They suit a call when deciding how to split AI/ML engineering between research and commercial teams, or whether to build biology foundation models in-house.
Professionals to explore
Abigail A. Flower, Ph.D.
LinkedInExperience: Former Director, Applied AI, AI/ML Engineering · GSK
$606 per 30-minute call
Former Director, Applied AI, AI/ML Engineering at GSK (2022–2026), Abigail A. Flower, Ph.D. was President and Chief Executive Officer at AI Zwei (2020–2022) and Assistant Professor, School of Data Science at the University of Virginia (2018–2020). Most recently Inaugural Director of the Center for Emerging Technologies at the University of New England (2026). Four years as Director, Applied AI at GSK, plus a company CEO role, suit questions on turning models into applied tools.
Is this you? Claim your profile and get paid for calls.
Emma Slade
LinkedInExperience: Senior Director of AI ML Engineering · GSK
$640 per 30-minute call
Emma Slade leads the Foundation Models team within AIML as Senior Director of AI ML Engineering at GSK since 2026. Head of Applied AI at Tangram Therapeutics (2025–2026); GSK roles before that were Director of AI ML Engineering (2024–2025), Senior AI ML Engineer (2022–2024) and AI Fellow (2020–2022). The natural first call on building foundation models inside a drugmaker.
Is this you? Claim your profile and get paid for calls.
Francisco Cruz
LinkedInExperience: Sr. Director Decision Science & AI - Global Commerical · GSK
$640 per 30-minute call
On the commercial side, Francisco Cruz has been Sr. Director Decision Science & AI - Global Commerical at GSK since 2023, after Director Data Science - Global Commercial Data & Analytics (2020–2023), where Cruz directed a global data science team located in the US, UK, India and Japan. Cruz was also Senior Principal Data Scientist at CBS (2018–2020) and Scientist in Applied Math and Modeling at Merck (2006–2015). The fit for commercial AI questions.
Is this you? Claim your profile and get paid for calls.
Gal Keinan
LinkedInExperience: Director of AI & Machine Learning · GSK
$573 per 30-minute call
Director of AI & Machine Learning at GSK since 2026, Gal Keinan previously held Senior AI ML Researcher (2023–2026) and Machine Learning Researcher (2021–2023) there. Intel roles were Data Science Researcher (2019–2021) and Analog Design Engineer (2011–2019). Keinan moved from researcher titles into a director title at GSK, useful for questions on bringing ML researchers into engineering leadership.
Is this you? Claim your profile and get paid for calls.
Jonathan L. Golob
LinkedInExperience: Director, AI ML Vaccines & Infectious Disease · GSK
$573 per 30-minute call
Jonathan L. Golob is a board-certified physician in internal medicine and infectious disease who also writes production machine-learning code, and has been Director, AI ML Vaccines & Infectious Disease at GSK since 2025, after Lead Engineer of AI ML for Vaccines and Infectious Disease (2024–2025). Also Core Scientific Lead & Organizer AI for Antimicrobial Resistance at The Fleming Initiative since 2024 and Assistant Professor at the University of Michigan (2018–2024).
Is this you? Claim your profile and get paid for calls.
Katie Aiello
LinkedInExperience: Executive Director, AI/ML Engineering · GSK
$740 per 30-minute call
Katie Aiello has been Executive Director, AI/ML Engineering at GSK since 2026, with Senior Director, AI/ML Engineering (2021–2026), Director, AI/ML Engineering (2019–2021) and Senior Machine Learning Engineer (2019) also at GSK. Lead AI Engineer, Clinical AI at Genentech (2018–2019) came just before. Seven years of AI/ML engineering titles at GSK make Aiello a fit for questions on how an AI/ML engineering group is organized.
Is this you? Claim your profile and get paid for calls.
Laura Acqualagna
LinkedInExperience: Senior Director of AI/ML Engineerig, R&D · GSK
$640 per 30-minute call
Laura Acqualagna holds Senior Director of AI/ML Engineerig, R&D at GSK (since 2026) and has been an Associate GSK Fellow since 2019; earlier GSK titles are Director of AI/ML Engineering, GSK R&D (2023–2026), Manager, Sr. Machine Learning Engineer, R&D (2019–2023) and a 2016–2019 R&D data scientist role. Acqualagna provides leadership across computational pathology, multimodal data integration and oncology, which fits questions on AI in biomedical research.
Is this you? Claim your profile and get paid for calls.
Lena Granovsky
LinkedInExperience: Former Senior Director of Artificial Intelligence and Machine Learning · GSK
$640 per 30-minute call
Since 2022, Lena Granovsky has been Senior Director of Artificial Intelligence and Machine Learning at GSK, following Director of Artificial Intelligence and Machine Learning there (2020–2022). Teva Pharmaceuticals roles include Senior Director, Head of Analytics and Big Data (2020) and Director, Head of Analytics and Big Data (2018–2020). Analytics leadership at Teva and AI/ML leadership at GSK give a view across two drugmakers.
Is this you? Claim your profile and get paid for calls.
Paul Elliott
LinkedInExperience: Senior Director of Engineering, AI/ML · GSK
$640 per 30-minute call
With Senior Director of Engineering, AI/ML at GSK since 2025 and Director of Engineering, AI/ML there from 2023 to 2025, Paul Elliott came to GSK from Google, where the title was Software Engineer (2020–2023). Also Manager, Data Science at Zume Inc. (2019–2020) and Data Team Lead at MyMusicTaste (2016–2018). A software engineering background suits questions on platform and engineering practice for pharma AI.
Is this you? Claim your profile and get paid for calls.
Paul Smyth
LinkedInExperience: Senior Director, AI/ML Engineering · GSK
$640 per 30-minute call
A theoretical physicist turned machine learning engineer, Paul Smyth leads the Controllable Biology and Sequence Learning team at GSK AIML and has held Senior Director, AI/ML Engineering at GSK since 2026. GSK titles also include Director, AI/ML Engineering (2022–2026), Staff AI/ML Engineer gsk.ai (2022), Senior AI/ML Engineer (2021–2022) and Senior Manager Data Science Capabilities (2019–2021). Fits questions on sequence models for biology.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
For research-side model work, the strongest matches are Emma Slade (Foundation Models team), Paul Smyth (Controllable Biology and Sequence Learning) and Laura Acqualagna (R&D, computational pathology and oncology). Francisco Cruz is the one commercial-side leader, and Jonathan L. Golob covers vaccines and infectious disease. For how the engineering organization is built, Katie Aiello and Paul Elliott hold the broadest engineering titles.
Questions to take into the conversation
- 01How does GSK decide which AI/ML engineering work sits with R&D teams and which sits with a central AI group?
- 02What does a pharmaceutical company need in data and compute before training its own foundation models for biology?
- 03How does a commercial decision science team at GSK share methods with the research-side AI teams?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.